Here you'll find Dr. Anderson's IV Monographs

You can view or download each IV Monograph individually below or download the whole collection.

1 HDIVC Information for Patients and Physicians

Intravenously administered high dose ascorbic acid (HDIVC) as used in cases of patients who have cancer has considerable mythology surrounding it. The purpose of this review is not to exhaustively recap the data regarding this therapy but rather to address basicissues of safety, pharmacology and outcomes of ongoing research.

1A ASC and PG

Much conjecture and mythology surrounds the use of vitamin C during pregnancy. A review of clinical use and safety as well as the limited data regarding this topic leads to a different safety profile for vitamin C in pregnancy than often reported.

2 Ascorbate IV Pharmocologic Basis for Stability

The pharmacologic stability of vitamins and minerals in parenteral solutions is reasonably well studied and published, but becomes a confusing data set when attempting to apply the available data to particular admixtures.

2a Ascorbate IV Oxidant Data, Laboratory Measurement and Safety

Much conjecture and mythology surrounds the use of vitamin C during pregnancy. A review of clinical use and safety as well as the limited data regarding this topic leads to a different safety profile for vitamin C in pregnancy than often reported.

2a Ascorbate IV Oxidant Data, Laboratory Measurement and Safety

Much conjecture and mythology surrounds the use of vitamin C during pregnancy. A review of clinical use and safety as well as the limited data regarding this topic leads to a different safety profile for vitamin C in pregnancy than often reported.

3 Ascorbate Oxidative vs Non-Oxidative Dosing

Oxidative versus Non-oxidative dosing of High and Low Dose Intravenous Ascorbic Acid as used by Bastyr University Clinical Research Center (BCRC) and Anderson Medical Specialty Associates (AMSA)

4 Ascorbate and Electrolytes with Formulas

In an interventional study associated with BIORC and AMSA we attempted to answer the questions regarding electrolyte shifts and HDIVC administration.

4a IV High Dose Vitamin C Formulas

The following four IV Vitamin C formulas are used for oxidative therapies.

5 Ascorbate General Protocol Guidelines and IV Intake and Agent Guidelines

General Treatment Protocol for the use of Intravenous Ascorbic Acid as used by Bastyr University Clinical Research Center (BCRC) and Anderson Medical Specialty Associates

5a High Dose IV Vitamin C in Marginal Kidney Function

HDIVC in cases of marginal GFR:

6 Ascorbate and Oncologic Therapies

Updated Data Review and Policies for concurrent use at Anderson Medical Specialty Associates, Southwest College of Naturopathic Medicine Research Institute and Medical Center and Bastyr University Clinical Research Center

6A - 2019 IVC, Antioxidant – Chemo and Radiation Update

For whatever reasons this gem of an old paper is making a resurgence at many oncologists offices and being used as a justification to not start IVC, HDIVC etc.

6B - Leukemia and Oxidative Therapies Including Intravenous Ascorbic Acid / HDIVC

A seeming conundrum regarding the ability of some leukemic cells (i.e. CLL) to sequester ascorbate (ASC) has led to confusion regarding the safety and utility of high dose ascorbate delivered via IV (HDIVC). This has led to some apparent confusion between this concern and the apparent positive benefits of HDIVC seen in clinical practice.

6C - Chelation, Detoxification, Magnesium, other Mineral levels and Platinum Based Chemotherapies

Question:
I have been told that we should wait two or more years after platinum based chemotherapy to begin any detoxification. But I have now heard conflicting information – has something changed?

7 IV Therapy Compatibility Chart

8 Radiation Injury Therapy and GSH

Rationale and formula developed for the BIORC – AMSA Clinics during the integrative oncology study.

8a GSH Augmentation and Cell Protection

Glutathione
Use in cell repair and augmentation of parenteral glutathione before and after administration:
Rationale and formula developed for the BIORC – AMSA Clinics during the integrative oncology study.

10 DCA Summary final 2014

As used at Anderson Medical Specialty Associates and in the Bastyr University Clinical Research Center (BCRC).

11 LipoicAcidMineralComplex-Monograph

11A Poly-LAMC Safety and Uses Anderson

11B Metabolic Therapies - Full Paper and Patient Handout - 2020 UPDATE

11C Metabolic Therapy Townsend 08-18

12 Curcumin IV Monograph Anderson

13 Artesunate IV Monograph Anderson

14 Silibinin Summary Anderson

15 Germanium Sesquioxide Summary Anderson

16 Glycyrrhizin Summary Anderson

17 Resveratrol Summary Anderson

18 Quercetin Summary Anderson